Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 82 of the 84 references it cites were found in a registry or an index.

Investigating Snake-Venom-Induced Dermonecrosis and Inflammation Using an Ex Vivo Human Skin Model

Open access

Abstract

Snakebite envenoming is a neglected tropical disease that causes >100,000 deaths and >400,000 cases of morbidity annually. Despite the use of mouse models, severe local envenoming, defined by morbidity-causing local tissue necrosis, remains poorly understood, and human-tissue responses are ill-defined. Here, for the first time, an ex vivo, non-perfused human skin model was used to investigate temporal histopathological and immunological changes following subcutaneous injections of venoms from medically important African vipers (Echis ocellatus and Bitis arietans) and cobras (Naja nigricollis and N. haje). Histological analysis of venom-injected ex vivo human skin biopsies revealed morphological changes in the epidermis (ballooning degeneration, erosion, and ulceration) comparable to clinical signs of local envenoming. Immunostaining of these biopsies confirmed cell apoptosis consistent with the onset of necrosis. RNA sequencing, multiplex bead arrays, and ELISAs demonstrated that venom-injected human skin biopsies exhibited higher rates of transcription and expression of chemokines (CXCL5, MIP1-ALPHA, RANTES, MCP-1, and MIG), cytokines (IL-1β, IL-1RA, G-CSF/CSF-3, and GM-CSF), and growth factors (VEGF-A, FGF, and HGF) in comparison to non-injected biopsies. To investigate the efficacy of antivenom, SAIMR Echis monovalent or SAIMR polyvalent antivenom was injected one hour following E. ocellatus or N. nigricollis venom treatment, respectively, and although antivenom did not prevent venom-induced dermal tissue damage, it did reduce all pro-inflammatory chemokines, cytokines, and growth factors to normal levels after 48 h. This ex vivo skin model could be useful for studies evaluating the progression of local envenoming and the efficacy of snakebite treatments.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/toxins16060276

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Macroscopic changes in venom-injected biopsies. Venoms (E. ocellatus 120 μg; B. arietans 195 μg; N. nigricollis 165 μg; N. haje 156 μg) were injected into Hyposkin® biopsies 15 mm in diameter and 10 mm thick, consisting of three skin layers (epidermis, dermis, and subcutis), and observed on day seven (168 h) for macroscopic changes. Day 0 refers to the time before subcutaneous injection. After seven days in culture, the untreated control and the biopsy injected with N. haje venom did not display any morphological changes. All other biopsies exhibited lesions, the most pronounced being caused by B. arietans venom (black circle shows area of change). Photographs captured with an MC170 HD camera.
Figure 1 Macroscopic changes in venom-injected biopsies. Venoms (E. ocellatus 120 μg; B. arietans 195 μg; N. nigricollis 165 μg; N. haje 156 μg) were injected into Hyposkin® biopsies 15 mm in diameter and 10 mm thick, consisting of three skin layers (epidermis, dermis, and subcutis), and observed on day seven (168 h) for macroscopic changes. Day 0 refers to the time before subcutaneous injection. After seven days in culture, the untreated control and the biopsy injected with N. haje venom did not display any morphological changes. All other biopsies exhibited lesions, the most pronounced being caused by B. arietans venom (black circle shows area of change). Photographs captured with an MC170 HD camera.CC BY · PubMed Central
Figure 2 Structural integrity and viability assessments of HypoSkin® models seven days following the subcutaneous injection of snake venoms. HypoSkin® models at day seven following subcutaneous injection of snake venoms (E. ocellatus 120 μg; B. arietans 195 μg; N. nigricollis 165 μg; N. haje 156 μg): (A) haematoxylin and eosin staining, (B) anti-active caspase-3 fluorescence immunostaining, and (C) DNA fragmentation determination by TUNEL staining. Black arrows indicate pyknotic nuclei in epidermal crests for the N. haje venom-injected biopsy. The examination of apoptotic cells using anti-active caspase-3 fluorescence immunostaining detected apoptotic cells (white arrows) in all conditions except the untreated control and the PBS-injected control. TUNEL staining confirmed the presence of either apoptotic cells (white arrows) or necrotic cells (yellow arrows) in all biopsies injected with venom. Untreated biopsies did not present any apoptotic or necrotic cells. Images were taken at 40× magnification; this showed the overall extent of the epidermal loss (erosion/ulceration).
Figure 2 Structural integrity and viability assessments of HypoSkin® models seven days following the subcutaneous injection of snake venoms. HypoSkin® models at day seven following subcutaneous injection of snake venoms (E. ocellatus 120 μg; B. arietans 195 μg; N. nigricollis 165 μg; N. haje 156 μg): (A) haematoxylin and eosin staining, (B) anti-active caspase-3 fluorescence immunostaining, and (C) DNA fragmentation determination by TUNEL staining. Black arrows indicate pyknotic nuclei in epidermal crests for the N. haje venom-injected biopsy. The examination of apoptotic cells using anti-active caspase-3 fluorescence immunostaining detected apoptotic cells (white arrows) in all conditions except the untreated control and the PBS-injected control. TUNEL staining confirmed the presence of either apoptotic cells (white arrows) or necrotic cells (yellow arrows) in all biopsies injected with venom. Untreated biopsies did not present any apoptotic or necrotic cells. Images were taken at 40× magnification; this showed the overall extent of the epidermal loss (erosion/ulceration).CC BY · PubMed Central
Figure 3 Measurements of the fluorescence intensities of HypoSkin® models seven days following the subcutaneous injection of snake venoms. HypoSkin® models at day seven following subcutaneous injection of snake venoms (E. ocellatus 120 μg; B. arietans 195 μg; N. nigricollis 165 μg; N. haje 156 μg), showing: (A) anti-active caspase-3 fluorescence immunostaining, and (B,C) DNA fragmentation determination by TUNEL staining. ImageJ software version 1.54 was used to quantify the fluorescence of apoptotic cells following anti-active caspase-3 fluorescence immunostaining, and the presence of apoptotic cells or necrotic cells following TUNEL staining. Bars represent means of triplicate measurements, and error bars represent standard deviation. Statistical significance was determined via ANOVA with Dunnett’s multiple comparison test, with asterisks indicating thresholds of * p ≤ 0.01, ** p < 0.008, *** p < 0.0002, and **** p < 0.0001. Note the different y-axis scales in (A) compared with (B,C).
Figure 3 Measurements of the fluorescence intensities of HypoSkin® models seven days following the subcutaneous injection of snake venoms. HypoSkin® models at day seven following subcutaneous injection of snake venoms (E. ocellatus 120 μg; B. arietans 195 μg; N. nigricollis 165 μg; N. haje 156 μg), showing: (A) anti-active caspase-3 fluorescence immunostaining, and (B,C) DNA fragmentation determination by TUNEL staining. ImageJ software version 1.54 was used to quantify the fluorescence of apoptotic cells following anti-active caspase-3 fluorescence immunostaining, and the presence of apoptotic cells or necrotic cells following TUNEL staining. Bars represent means of triplicate measurements, and error bars represent standard deviation. Statistical significance was determined via ANOVA with Dunnett’s multiple comparison test, with asterisks indicating thresholds of * p ≤ 0.01, ** p < 0.008, *** p < 0.0002, and **** p < 0.0001. Note the different y-axis scales in (A) compared with (B,C).CC BY · PubMed Central
Figure 4 Histology of biopsies at time points 6, 12, 24, 36, and 48 h following subcutaneous injection of snake venoms. After venoms (E. ocellatus 120 μg; B. arietans 195 μg; N. nigricollis 165 μg; N. haje 156 μg) were subcutaneously injected into HypoSkin® models, 5 μm skin sections were stained with haematoxylin and eosin; these are shown at 4× magnification. Variation is seen between samples, even those treated with the same venom, and later time points do not always show a progression of epidermis degeneration. Images were taken at 4× magnification to demonstrate the overall extent of epidermal loss (erosion/ulceration).
Figure 4 Histology of biopsies at time points 6, 12, 24, 36, and 48 h following subcutaneous injection of snake venoms. After venoms (E. ocellatus 120 μg; B. arietans 195 μg; N. nigricollis 165 μg; N. haje 156 μg) were subcutaneously injected into HypoSkin® models, 5 μm skin sections were stained with haematoxylin and eosin; these are shown at 4× magnification. Variation is seen between samples, even those treated with the same venom, and later time points do not always show a progression of epidermis degeneration. Images were taken at 4× magnification to demonstrate the overall extent of epidermal loss (erosion/ulceration).CC BY · PubMed Central
Figure 5 Histologies of venom- and antivenom-injected biopsies. Images show HypoSkin® sections 48 h following subcutaneous injection of snake venom only, or venom then followed by antivenom at 48 h: (A) E. ocellatus, venom only (120 μg); (B) E. ocellatus, venom (120 μg) followed by SAIMR Echis monovalent antivenom (20 µL) at 48 h; (C) N. nigricollis, venom only (165 μg); and (D) N. nigricollis, venom (165 μg) followed by SAIMR polyvalent antivenom at 48 h. Skin sections were stained with haematoxylin and eosin, and images taken at 4× magnification. Arrows indicate locations of epidermal loss (ulceration), which was present even with antivenom treatment at 48 h. Images were taken at 4× magnification to demonstrate the overall extent of the epidermal loss (erosion/ulceration).
Figure 5 Histologies of venom- and antivenom-injected biopsies. Images show HypoSkin® sections 48 h following subcutaneous injection of snake venom only, or venom then followed by antivenom at 48 h: (A) E. ocellatus, venom only (120 μg); (B) E. ocellatus, venom (120 μg) followed by SAIMR Echis monovalent antivenom (20 µL) at 48 h; (C) N. nigricollis, venom only (165 μg); and (D) N. nigricollis, venom (165 μg) followed by SAIMR polyvalent antivenom at 48 h. Skin sections were stained with haematoxylin and eosin, and images taken at 4× magnification. Arrows indicate locations of epidermal loss (ulceration), which was present even with antivenom treatment at 48 h. Images were taken at 4× magnification to demonstrate the overall extent of the epidermal loss (erosion/ulceration).CC BY · PubMed Central
Figure 6 Changes in pro-inflammatory chemokines, cytokines, and growth factors following Echis ocellatus, Bitis arietans, Naja nigricollis, and N. haje venom subcutaneous injections in HypoSkin® biopsies. Pro-inflammatory responses were quantified by (A) RNA sequencing of HypoSkin® tissue following venom and antivenom treatments over 48 h, and by using the (B) Human Cytokine Magnetic 30-Plex Panel, with culture media collected at 6, 12, 24, 36, 48, 72, 96, and 120 h following venom treatments.
Figure 6 Changes in pro-inflammatory chemokines, cytokines, and growth factors following Echis ocellatus, Bitis arietans, Naja nigricollis, and N. haje venom subcutaneous injections in HypoSkin® biopsies. Pro-inflammatory responses were quantified by (A) RNA sequencing of HypoSkin® tissue following venom and antivenom treatments over 48 h, and by using the (B) Human Cytokine Magnetic 30-Plex Panel, with culture media collected at 6, 12, 24, 36, 48, 72, 96, and 120 h following venom treatments.CC BY · PubMed Central
Figure 7 Dynamic changes in the expression, and secretion into culture media, of pro-inflammatory chemokines, cytokines, and growth factors of human skin biopsies injected with viper (Echis ocellatus and Bitis arietans) and elapid (Naja nigricollis and N. haje) venoms. The Human Cytokine Magnetic 30-Plex Panel for the Luminex™ platform was used to quantify pro-inflammatory responses in culture media collected from the venom-injected HypoSkin® biopsies over 120 h and 48 h following antivenom intervention. Data are shown for four chemokines, namely, (A) MCP-1, (B) RANTES, (C) MIP1-ALPHA, and (D) MIG; five cytokines, namely, (E) IL-1β, (F) IL-1RA, (G) IL-12, (H) G-CSF/CSF-3, and (I) GM-CSF; and three growth factors, namely, (J) HGF, (K) FGF-Basic, and (L) VEGF-A. Cell-culture media collected from untreated HypoSkin® biopsies were used for response comparisons. Eocc + AV, E. ocellatus + SAIMR Echis antivenom; N.nig + AV, N. nigricollis + SAIMR polyvalent antivenom.
Figure 7 Dynamic changes in the expression, and secretion into culture media, of pro-inflammatory chemokines, cytokines, and growth factors of human skin biopsies injected with viper (Echis ocellatus and Bitis arietans) and elapid (Naja nigricollis and N. haje) venoms. The Human Cytokine Magnetic 30-Plex Panel for the Luminex™ platform was used to quantify pro-inflammatory responses in culture media collected from the venom-injected HypoSkin® biopsies over 120 h and 48 h following antivenom intervention. Data are shown for four chemokines, namely, (A) MCP-1, (B) RANTES, (C) MIP1-ALPHA, and (D) MIG; five cytokines, namely, (E) IL-1β, (F) IL-1RA, (G) IL-12, (H) G-CSF/CSF-3, and (I) GM-CSF; and three growth factors, namely, (J) HGF, (K) FGF-Basic, and (L) VEGF-A. Cell-culture media collected from untreated HypoSkin® biopsies were used for response comparisons. Eocc + AV, E. ocellatus + SAIMR Echis antivenom; N.nig + AV, N. nigricollis + SAIMR polyvalent antivenom.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 84 references

Research works printed but not linked: 1

  1. Warrell, 1999, The Clinical Management of Snake Bites in the Southeast Asian Region, Southeast Asian J. Trop. Med. Public Helath, 30, 1

Cited by

See all 8

Metadata

Authors
Alsolaiss, J., Leeming, G., Da Silva, R., Alomran, N., Casewell, N. R., Habib, A. G., Harrison, R. A., & Modahl, C. M.
Affiliations
  • Liverpool School of Tropical Medicine (GB)
  • University of Liverpool (GB)
  • Centre for Snakebite Research and Interventions, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK
  • Bayero University Kano (NG)
Corresponding author
Alsolaiss, Jaffer
Venue
Toxins
Publisher
MDPI AG
Published
2024-06-17
Volume
16
Issue
6
Pages
276
ISSN
2072-6651 (ISSN-L)
OpenAlex
W4399738306
Cited by
8
References
84
Citations by year
2026: 4 · 2025: 4
FWCI
2.12
Type
journal article
Language
en
Open access
Locations
  • Toxins (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LSTM Online Archive (Liverpool School of Tropical Medicine) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Saudi Cultural Bureau (221708/Z/20/Z, 223619/Z/21/Z, SBF008\1127)
  • Wellcome Trust snakebite (221708/Z/20/Z, 223619/Z/21/Z, SBF008\1127)
  • AMS Springboard (221708/Z/20/Z, 223619/Z/21/Z, SBF008\1127)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Venomous Animal Envenomation and Studies
  • Life Sciences › Agricultural and Biological Sciences › Ecology, Evolution, Behavior and Systematics › Amphibian and Reptile Biology
  • Health Sciences › Medicine › Pharmacology (medical) › Healthcare and Venom Research
Keywords
snakebite, dermonecrosis, ex vivo human skin model, Echis ocellatus, Bitis arietans, Naja nigricollis, Naja haje, antivenom efficacy, chemokines, cytokines, growth factors, apoptosis, epidermal necrosis, inflammation
MeSH terms
Animals, Elapid Venoms, Humans, Inflammation, Necrosis, Skin, Snake Bites, Viper Venoms, Cytokines, Viperidae, Chemokines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Investigating Snake-Venom-Induced Dermonecrosis and Inflammation Using an Ex Vivo Human Skin Model. https://app.cochat.ai/papers/10.3390/toxins16060276
The paper
Alsolaiss, J., Leeming, G., Da Silva, R., Alomran, N., Casewell, N. R., Habib, A. G., Harrison, R. A., & Modahl, C. M. (2024). Investigating Snake-Venom-Induced Dermonecrosis and Inflammation Using an Ex Vivo Human Skin Model. Toxins. https://doi.org/10.3390/toxins16060276

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.